Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))
Condition(s):Erythropoietic Protoporphyria (EPP)Last Updated:June 24, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Erythropoietic Protoporphyria (EPP)Last Updated:June 24, 2021Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:October 10, 2019Completed
Condition(s):EPP; XLPLast Updated:March 13, 2024Active, not recruiting
Condition(s):Erythropoietic Protoporphyria; EPP; X-Linked Protoporphyria; XLP; XLPP; X-Linked Dominant Erythropoietic Protoporphyria; XLEPP; XLDPLast Updated:April 17, 2020Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:April 25, 2017Completed
Condition(s):Mental Health Impairment; Mental Health Disorder; Psychosocial ProblemLast Updated:February 8, 2023Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:September 19, 2019Completed
Condition(s):Covid19Last Updated:September 30, 2020Completed
Condition(s):Erythropoietic Protoporphyria (EPP)Last Updated:February 28, 2024Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:October 2, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.